Advertisement
For commonly prescribed cardiovascular drugs

Drug Prices Seem Not to Be Influenced by Their Value

0
Incremental cost-effectiveness ratio of 30 heart medications varied from cost-saving to costly
Association health plans will provide small businesses with more choices

Association Health Plans Can Help Small Businesses Offer Coverage

0
But AHPs may undermine ACA marketplace, as they are not required to comply with ACA regulations
A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients with chronic obstructive pulmonary disease but no difference in exacerbations

Small Reduction in Lung Function With Tx De-Escalation in COPD

0
No difference in exacerbations with indacaterol/glycopyrronium for non-frequently exacerbating COPD
Identifying and reducing diagnostic errors in the intensive care unit should be a top priority

Recommendations Issued for Enhancing ICU Diagnostic Safety

0
Include enhancing recognition of potential errors, increasing teamwork, patient-centeredness
For patients undergoing rhinoplasty

Opioid Refills Rare After Rhinoplasty

0
Only 1.2 percent of patients prescribed opioids required refills within three weeks of surgery
Supplementation with folic acid beyond the first trimester does not prevent preeclampsia among high-risk women

Folic Acid Past First Trimester Doesn’t Prevent Preeclampsia

0
Supplementation beyond first trimester does not reduce risk of preeclampsia in high-risk women
More than one-quarter of older adults newly prescribed benzodiazepine by an non-psychiatric clinician transition to long-term use

Many Older Adults Transition to Long-Term Benzodiazepine Use

0
Factors linked to long-term use include white race, days in index prescription, poor sleep quality
Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia

FDA Approves Novel Treatment for Hairy Cell Leukemia

0
Lumoxiti, a CD22-directed cytotoxin, approved for adults who have had at least two prior therapies
The U.S. Food and Drug Administration warns that it has found a second impurity in three lots of Torrent Pharmaceuticals' valsartan drug products.

FDA Finds Another Carcinogen in Certain Valsartan Heart Meds

0
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
Lesbian

Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults

0
However, in post-ACA era, lesbian, gay, bisexual adults still report trouble affording care